Company profile: US BioTek
1.1 - Company Overview
Company description
- Provider of CLIA-accredited immunology and chemistry testing services for clinicians worldwide, including food sensitivity (IgG, IgG4, IgA), food allergy (IgE), inhalant/aeroallergen (IgG, IgG4, IgA, IgE), microbiome, organic acids, and environmental pollutants testing, backed by over 30 years of experience in ELISA technology. Headquartered in Shoreline, Washington.
Products and services
- Food Allergy Testing: ELISA-based assay measures IgE antibodies to specific foods, identifying allergic reactions for clinicians worldwide
- Food Sensitivity Testing: CLIA-accredited testing evaluates IgG, IgG4, and IgA antibodies to diverse foods to identify sensitivities and intolerances for clinicians worldwide
- Inhalant/Aeroallergen Testing: Immunology-profile testing assesses IgG, IgG4, IgA, and IgE responses to common airborne allergens to depict exposure-related sensitivity patterns for clinicians
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to US BioTek
Bio Products Laboratory
HQ: United States
Website
- Description: Provider of plasma collection and plasma-derived medicines, headquartered in the UK and delivering life-saving treatments worldwide for immune deficiencies, bleeding disorders, infectious diseases, and critical care. Operates 29 US donor centers and supplies human albumin (approved for the Chinese market), plus immunology, critical care, and coagulation disorder products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bio Products Laboratory company profile →
Complete Genomics
HQ: United States
Website
- Description: Provider of DNA sequencing platforms for human genome sequencing and analysis, supporting commercial-scale research into genetic mechanisms underlying drug responses and complex diseases. Offerings include DNBSEQ-T7 and DNBSEQ-T20x2 ultra-high throughput sequencers, DNBSEQ-G400 high throughput, DNBSEQ-G99 fast mid throughput, DNBSEQ-E25 portable, and CoolMPS for genomic analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Complete Genomics company profile →
myPOLS Biotec
HQ: Germany
Website
- Description: Provider of best-in-class DNA polymerases, master mixes, DNA polymerase-based assays, and reagents in liquid and lyophilized formats for IVD and research use, based in Konstanz, Germany.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full myPOLS Biotec company profile →
Ion Torrent
HQ: United States
Website
- Description: Provider of sequencing technology that enables a direct connection between chemical and digital information; the first commercial PostLight sequencing technology that doesn't use light. Ion Torrent is a wholly-owned subsidiary of Life Technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ion Torrent company profile →
LifeMine Therapeutics
HQ: United States
Website
- Description: Provider of genomics-, AI-, and synthetic biology-enabled drug discovery and development leveraging evolutionary insights from fungi. Offerings include Top-Down Drug Discovery and Avatar-Rx platforms, the LifeBank collection of 100,000 deep-sequenced wild-type fungi spanning over 25,000 species, pipeline programs such as LIFE-001 for transplantation and an anti-fungal portfolio, plus a GSK alliance to identify novel small-molecule leads for multiple disease areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LifeMine Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for US BioTek
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to US BioTek
2.2 - Growth funds investing in similar companies to US BioTek
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for US BioTek
4.2 - Public trading comparable groups for US BioTek
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →